The Protective Effect of Amifostine on Radiation-Induced Proctitis: Systemic Versus Topical Application
dc.authorid | Özen, Alaattin/0000-0001-9219-6001 | |
dc.authorid | Özen, Alaattin/0000-0001-9219-6001 | |
dc.authorid | Yağcı, Meral Apaydın/0000-0002-2108-1853 | |
dc.authorwosid | Özen, Alaattin/ABG-9988-2020 | |
dc.authorwosid | Özen, Alaattin/IZQ-0388-2023 | |
dc.authorwosid | Yağcı, Meral Apaydın/AAY-6875-2021 | |
dc.contributor.author | Uzal, Cem | |
dc.contributor.author | Sezer, Atakan | |
dc.contributor.author | Usta, Ufuk | |
dc.contributor.author | Sut, Necdet | |
dc.contributor.author | Ozen, Alaattin | |
dc.contributor.author | Yagci, Mehmet All | |
dc.date.accessioned | 2024-06-12T10:51:24Z | |
dc.date.available | 2024-06-12T10:51:24Z | |
dc.date.issued | 2012 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objective: The aim of the study was to evaluate the radioprotective efficacy of intrarectal administration of amifostine in radiation-induced proctitis compared to intraperitoneal administration. Materials and Methods: Thirty-two Sprague-Dawley rats were randomly divided into four groups: Control (CONT), irradiation alone (RI), intraperitoneal amifostine plus irradiation (IPAMI), and intrarectal amifostine plus irradiation (IRAMI). The rats in the RI, IPAMI and IRAMI groups were irradiated individually with a single dose of 17.5 Gy to the pelvis. Amifostine was administered by the intraperitoneal (200 mg/kg) or intrarectal (2000 mg/kg) route before irradiation. Histopathologic analysis of the rectum was performed 14 days after irradiation. Results: Significant radiation damage appeared in all histopathologic parameters and was reduced by amifostine. Pretreatment with IPAMI significantly reduced the inflammatory infiltrate in the lamina propria (p=0.021), cryptitis (p=0.002) and crypt abscess (p=0.015). However, the protective effect of IRAMI was significant for all parameters with equal or higher significance than IPAMI, including the eosinophil leucocytes count (p=0.02), and distortion of the crypts (p=0.008), and was also significant for regenerative/reparative atypia (p=0.013). Conclusion: Intrarectal high dose topical administration of amifostine is more effective in the prevention of radiation-induced proctitis compared to its intraperitoneal systemic administration. | en_US |
dc.identifier.doi | 10.5152/balkanmedj.2011.005 | |
dc.identifier.endpage | 38 | en_US |
dc.identifier.issn | 2146-3123 | |
dc.identifier.issn | 2146-3131 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-84862112912 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 32 | en_US |
dc.identifier.uri | https://doi.org/10.5152/balkanmedj.2011.005 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/18357 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:000303618400007 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Balkan Medical Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Amifostine | en_US |
dc.subject | Proctitis | en_US |
dc.subject | Irradiation | en_US |
dc.subject | Radioprotection | en_US |
dc.subject | Late Rectal Injury | en_US |
dc.subject | Small-Intestine | en_US |
dc.subject | Intrarectal Amifostine | en_US |
dc.subject | Prostate-Cancer | en_US |
dc.subject | Rat Model | en_US |
dc.subject | Radiotherapy | en_US |
dc.subject | Therapy | en_US |
dc.subject | Prevention | en_US |
dc.subject | Toxicity | en_US |
dc.subject | Fractionation | en_US |
dc.title | The Protective Effect of Amifostine on Radiation-Induced Proctitis: Systemic Versus Topical Application | en_US |
dc.type | Article | en_US |